SCHEMBL25006433

SCHEMBL25006433

CCCCC(C)/C(C)=N/C=C(\C)c1ccc(OC)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 3/20 0.38
▸ TAS1R3 Q7RTX0 2/20 0.38
▸ TAS1R1 Q7RTX1 2/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ HDAC3 O15379 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ NR1I2 O75469 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ MMP13 P45452 2/20 0.36
▸ MMP9 P14780 1/20 0.36
▸ SLC6A2 P23975 1/20 0.34
▸ SLC6A4 P31645 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ MMP1 P03956 1/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ MMP3 P08254 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19314647 0.83 BDKRB2 (0.33) —
SCHEMBL25006752 0.75 TAS1R3 (0.40) TAS1R3TAS1R1HDAC3HDAC1HDAC2
SCHEMBL931807 0.69 NR1I2 (0.43) TAS1R3TAS1R1HDAC3HDAC1HDAC2
SCHEMBL25008403 0.68 F2R (0.33) SLC6A2SLC6A4ALDH1A1CTSK
SCHEMBL27457534 0.68 HTT (0.52) TAS1R3TAS1R1HDAC3HDAC1HDAC2
SCHEMBL9440242 0.68 HTT (0.52) TAS1R3TAS1R1HDAC3HDAC1HDAC2
Hydrochloric Acid SCHEMBL30725888 0.68 HTT (0.56) TAS1R3TAS1R1HDAC3HDAC1HDAC2
SCHEMBL27314198 0.67 TAS1R3 (0.47) TAS1R3TAS1R1HDAC3HDAC1HDAC2
SCHEMBL18078301 0.65 TDP1 (0.66) NQO2TAS1R3TAS1R1HDAC3HDAC1
SCHEMBL21596587 0.65 TP53 (0.45) NQO2PTGS1PTGS2HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129402-A1 HYDROXYPYRROLIDINE DERIVATIVE AND MEDICINAL APPLICATION THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2023-02-08 — — EP disclosed
Send feedback